Parnax Lab Ltd

NSE: PARNAXLAB · BSE: 506128 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹117.10
Market cap: ₹134.5 Cr
Revenue (annual): ₹248.5 Cr
Net profit (annual): ₹11.78 Cr
P/E (TTM): 15.1×Sector 50.4×
Promoter holding: 72.30%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements

7 Sep 2026 17:24 IST BSE

Annual General Meeting

Parnax Lab Annual General Meeting

Parnax Lab Ltd announced its 44th Annual General Meeting scheduled for September 29, 2026, through video conferencing. The agenda includes appointing statutory auditors and related party transactions.

Read the filing ↗

7 Sep 2026 17:05 IST BSE

Annual Report

Parnax Lab Annual Report

Parnax Lab Ltd has submitted its 44th Annual Report for the financial year 2025-2026. The 44th AGM is scheduled for September 29, 2026.

Read the filing ↗

14 Aug 2026 17:22 IST BSE

Financial Results

Parnax Lab Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 87.9% YoY

Parnax Lab Ltd reported revenue from operations of ₹56.8 Cr (+6.4% YoY) and net profit of ₹0.4 Cr (-87.9% YoY) for Q1 FY27.

Key figure: Net profit ₹0.4 Cr · -87.9% YoY

Open full results → Read the filing ↗

28 May 2026 17:27 IST BSE

Financial Results

Parnax Lab Q4 FY26 Results: Net Profit ₹2.2 Cr, Down 24.1% YoY

Parnax Lab Ltd reported revenue from operations of ₹69.6 Cr (+42.0% YoY) and net profit of ₹2.2 Cr (-24.1% YoY) for Q4 FY26.

Key figure: Net profit ₹2.2 Cr · -24.1% YoY

Open full results → Read the filing ↗